Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Siemens, Medtronic jump through antitrust regulatory hoops

This article was originally published in Clinica

Executive Summary

US antitrust authorities has given the go-ahead to Siemens' proposed $7bn acquisition of Dade Behring, the German multinational's third and largest IVD transaction. Siemens began a tender offer for all issued and outstanding Dade stock, at $77 per share, on August 8 and has extended this offer until midnight September 26. The acquisition still requires EU antitrust approval - Siemens said it is in discussion with the European Commission and believes it can close the transaction during calendar 2007.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049774

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel